Ustekinumab therapy for Netherton syndrome.

Abstract excerpt

Netherton syndrome (NS) is a rare disorder of cornification associated with high morbidity. It is caused by bi-allelic mutations in SPINK5 encoding the serine protease inhibitor LEKTI. Previous studies have shown Th17 skewing with IL-23 upregulation in NS, raising the possibility that targeting these inflammatory pathways may alleviate disease manifestations. We ascertained the therapeutic efficacy of six doses...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ichthyosis
• Share to Mutation
• Share to Serine Peptidase Inhibitor Kazal-Type 5